Pepgen to host fourth quarter and full year 2022 financial results call

Boston, march 16, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, will report its fourth quarter and full year 2022 financial results and provide a corporate update on thursday, march 23, 2023. pepgen's management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30pm et.
PEPG Ratings Summary
PEPG Quant Ranking